BK

Bilagi Krushnamurthy Shruthi

Active Director Director DIN 10913322
DIN 10913322 First appointment Jan 2025 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Bilagi Krushnamurthy Shruthi

Data last updated:

Bilagi Krushnamurthy Shruthi is a Director at Emilycox Pharmaceuticals Private Limited (since 2025). The company operates in Pharma.

DIN 10913322
Primary Designation Director
Industry Pharma
First Appointment 20 Jan 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director20 Jan 20252025Active

Board colleagues of Bilagi Krushnamurthy Shruthi

Directorship timeline

Open interactive timeline →
Emilycox Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Bilagi Krushnamurthy Shruthi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Bilagi Krushnamurthy Shruthi

Bilagi Krushnamurthy Shruthi currently holds 1 directorship: Emilycox Pharmaceuticals Private Limited (Director, since 20 Jan 2025).

Bilagi Krushnamurthy Shruthi was first appointed on 20 Jan 2025 as Director at Emilycox Pharmaceuticals Private Limited.

The current boards of Bilagi Krushnamurthy Shruthi's companies include Basavenahalli Shivanna Lokesh Kumara (Emilycox Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available